|Videos|August 29, 2017

Patients Who Fail to Adhere to Recommended Medications: What Is the Solution?

John Rumsfeld, MD, PhD, chief innovation officer at the American College of Cardiology, discusses the vexing problem of patients who fail to fill or take recommended medications.

In this clip filmed at the 2017 European Society of Cardiology Congress, John Rumsfeld, MD, PhD, chief innovation officer at the American College of Cardiology, discusses the vexing problem of patients who fail to fill or take recommended medications.

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

Patients Who Fail to Adhere to Recommended Medications: What Is the Solution?

Newsletter

Related Content

Lingering Muscle Damage After Weight Restoration in Anorexia Nervosa May Require Long-Term Care

Rates of Missed MMR Vaccination Have Increased Since Pandemic

Pharmacist-Led Dietary Guidance Supports Kidney Health

Regimens, Adherence, and Adverse Events: The Role of the Pharmacist in Asthma Management

Explainer: What Do the New HHS Vaccine Changes Mean for Pharmacists?

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Empowering Patients With COPD: The Pharmacist's Role in Personalized Treatment Strategies

Implementing Updated RSV Vaccination Recommendations for Older Adults: Considerations for the Pharmacist (Part 3)

Implementing Updated RSV Vaccination Recommendations for Older Adults: Introduction and Disease Burden (Pharmacy Technician Credit)

Navigating Diabetes: A Guide to Effective Oral Treatments

Advancing Acute Pain Care: Breakthrough Non-Opioid Therapies and the Pharmacist's Critical Role

Hyperlipidemia Overview and the Clinical and Economic Burden

The Role of the Pharmacist in the Management of Hyperlipidemia

Leveraging Managed Care to Optimize Patient Outcomes: Integrating Novel Treatments in Schizophrenia

Beyond the Spots: Management of Measles

Exploring Therapeutic Advances in Myelofibrosis and Key Considerations for Effective Management

Updated Guidance and Managed Care Strategies to Optimize Respiratory Syncytial Virus Vaccination Coverage

Managed Care Approaches and Models for Equitable Access to Innovations in Major Depressive Disorder Treatment

Evaluating the Effectiveness and Value of Novel Nonhormonal Treatments in the Management of Menopause-Related Vasomotor Symptoms

Navigating the Advancements in Oral Therapy Options in HR+ Metastatic Breast Cancer

Navigating the Changing Treatment Paradigm of Metabolic Dysfunction-Associated Steatohepatitis: A Guide for Managed Care Pharmacists

Tracking a Moving Target in HR+ Metastatic Breast Cancer: Innovative Oral Therapies and Evolving Strategies

An Evolving Treatment Paradigm: Innovative Approaches and Critical Insights in the Management of Newly Diagnosed Multiple Myeloma

Advancing Care in HER2-Negative Early Breast Cancer: Essential Insights and Best Practices for Oncology Pharmacists

Exploring Therapeutic Advances in Myelofibrosis and Key Considerations for Effective Management

Transforming Lymphoma Treatment With Bispecific Antibodies: Practical Solutions for Oncology Pharmacy Teams

Navigating the World of Insulin: An Update on Types, Uses, and Considerations

PBM Challenges and the Evolving Role of Oncology Pharmacists in Community Practices

Streamlining Pharmacist-Led Hyperglycemia Management in HR+ Breast Cancer: Overcoming PI3K/AKT Inhibitor Challenges

Leveraging Biologics and Immunotherapies in the Management of Food Allergies

Advancing Care in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Optimizing Outcomes With Emerging Therapies

JAK(i) of All Trades: Navigating Myelofibrosis Treatment and Safety in Community Oncology Practice

Beyond Chimeric Antigen Receptor T-Cell Therapy: Comprehensive Approaches for Community Oncology Practices in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Advancing Chronic Lymphocytic Leukemia Treatment in the Community: Practical Updates and Clinical Pearls for Oncology Pharmacists

Transforming Metabolic Dysfunction-Associated Steatohepatitis Management: Pharmacist Considerations for the Evolving Treatment Landscape

Innovations in Inflammatory Bowel Disease Therapy: How IL-23 Inhibitors Are Shaping Treatment and Managed Care Approaches

Continuous Glucose Monitoring: What's New in 2025?

Demystifying CGM: Addressing Frequently Asked Questions and Key Insights

A Deep Dive Into CGM Data (Pharmacy Technician Credit)

Continuous Glucose Monitoring: What's New in 2025? (Pharmacy Technician)

A Deep Dive Into CGM Data

Advancing Stroke Prevention: The Pharmacist’s Role in Implementing the 2024 Guidelines

Advances and Innovations in Hypertrophic Cardiomyopathy Management: A Focus on New and Emerging Therapies

Understanding and Personalizing Chronic Obstructive Pulmonary Disease Diagnosis and Treatment

Respiratory Syncytial Virus Disease Prevention in Adults: The Pharmacist’s Role in Improving Vaccine Uptake

Discipline Decoded: Navigating Pharmacy Law and Disciplinary Cases

Directions in Pharmacy 2026

Leveraging Novel Therapies to Transform Demodex Blepharitis Care

The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmacist Credit)

Adapting to Advances in EGFR-Positive Non-Small Cell Lung Cancer Treatment: Critical Insights for Oncology Pharmacists

From Flares to Freedom: Navigating the Journey of Patients With Chronic Spontaneous Urticaria With Next-Generation Therapies

Addressing the Burden of Hemolysis in Paroxysmal Nocturnal Hemoglobinuria: The Pharmacist's Contribution to Patient Care

The Oncology Pharmacist's Role in Managing Small Molecule Inhibitor Use in Chronic Lymphocytic Leukemia to Enhance Patient-Centered Care

Advancing Pharmacist Expertise in R/R FL: Navigating Novel Therapies and Optimizing Patient Outcomes

Navigating Novel Therapies in Steroid-Refractory cGVHD: Practical Strategies for Community-Based Oncology Pharmacists

Reducing Transfusion Burden in Myeloid Disorders: Novel Therapeutic Strategies and Pharmacist Interventions

Optimizing Patient Outcomes in R/R DLBCL: Bridging Knowledge Gaps for Oncology Pharmacists in the Era of Novel Immunotherapies

Understanding mRNA Vaccines: Dispelling Myths and Empowering Pharmacists to Counsel Patients

Understanding mRNA Vaccines: Dispelling Myths and Empowering Pharmacists to Counsel Patients (Pharmacy Technician Credit)

Precision Matters: Foundations of Biomarker-Driven Care in Non-Small Cell Lung Cancer

From Testing to Treatment: Empowering Pharmacists to Overcome Barriers and Optimize Biomarker-Driven Care

Exploring Oncolytic Viruses in Melanoma: Pharmacist-Led Approaches for Safe Integration

Clinical Presentation of Hyperglycemia with PI3K and AKT Inhibitors

Optimizing Lipid Management in Statin-Intolerant Populations: Payer Strategies for Evidence-Based Access and Risk Reduction

Protecting Against Meningococcal Disease: Updates on Vaccines, Guidelines, and Pharmacist Best Practices

Addressing Vaccine Hesitancy in Infectious Disease Prevention

Bridging Innovation and Access in HR-Positive/HER2-Negative Metastatic Breast Cancer: Implications for Managed Care

Effective Strategies to Manage Hyperglycemia When Treating with PI3K and AKT Inhibitors

Multidisciplinary Insights and Strategies for Patients Treated With PI3K and AKT Inhibitors to Prevent Hyperglycemia

Cardiorenal Protection With SGLT2 Inhibitors: Perspectives for Managed Care

Minimizing Injection Burden: Anti-VEGF Innovation for Retinal Disease Management

Advancing Treatment Strategies in Extensive-Stage Small Cell Lung Cancer: Enhancing Pharmacist Competence in Therapy Selection, Administration, and Adverse Event Management

Transforming Gout Care: Navigating Barriers and Therapeutic Advances in Disease Management

Managing Overactive Bladder in Older Adults: Challenges and Strategies for Long-Term Care

Bridging Clinical and Access Gaps in Phenylketonuria: A Managed Care Perspective

Enhancing The Role of Oncology Pharmacists in Multidisciplinary Myeloproliferative Neoplasm Care